← Eichor
Condition: Hypoplastic Left Heart Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypoplastic Left Heart Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Fetal Aortic Valvuloplasty on Outcomes
Phase N/A · 13 location(s) · Queen Silvia Children's Hospital, Gothenburg, Sweden · NCT05386173
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Phase N/A · 63 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02852031
The Co-Op @ HeartWorks
Phase N/A · 1 location(s) · HeartWorks, Inc. · NCT06469918
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Diseas
Phase N/A · 1 location(s) · Beijing Anzhen Hospital · NCT06768008
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
Phase 3 · 4 location(s) · Metcela Inc. · NCT02781922
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
Phase N/A · 5 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06711666
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT04106479
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Phase 2 · 1 location(s) · Nationwide Children's Hospital · NCT04467671
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.